Prevalence of Circulating Autoantibodies Against G-Protein-Coupled Receptors as Potential Biomarkers for Long COVID: Preliminary Investigations
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27041787 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Marta Camici und 16 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy. Hauptthemen laut MEDLINE: Autoantibodies, COVID-19, Receptors, G-Protein-Coupled. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ricerca Corrente of the Italian Ministry of Health, Linea 1, Progetto 1, INMI L. Spallanzani I.R.C.C.S..
Abstract (Originalsprache)
This prospective, single-center, case-control study investigated circulating autoantibodies (AAbs) targeting G protein-coupled receptors (GPCRs) in Long COVID (LC) patients to identify potential diagnostic biomarkers and therapeutic targets. Fifteen participants were enrolled at the LC clinic in Rome: eleven with severe LC—defined as >4 persistent symptoms (fatigue, cognitive impairment, poor exercise tolerance, dyspnea, arthralgia, or dysautonomic manifestations) >3 months post-infection—and four asymptomatic post-COVID (APC) individuals. Fatigue was assessed using the Fatigue Assessment Scale (FAS ≥ 22; severe ≥ 35). Auto-Abs against AT1R, endothelin receptor A, adrenergic (α1, α2, β1, β2), and muscarinic (M1–M5) receptors were quantified, along with blood cortisol and ACTH levels. SARS-CoV-2-specific T-cell responses to Spike and Nucleocapsid proteins were evaluated by ELISpot assay. In our small cohort, LC patients were younger, had fewer comorbidities (p = 0.03), fewer vaccine doses (p = 0.03), and higher FAS scores (33 vs. 12; p = 0.001). Mean GPCR AAbs levels were higher in LC than in APC (8.88 vs. 5.45 Units/mL; p = 0.17), indicating a coherent autoimmune signature in LC that correlates with symptom development. Morning cortisol was lower in LC (12.7 vs. 17 mg/dL; p = 0.01), and T-cell responses tended to be weaker. These findings suggest GPCR AAbs may serve as biomarkers and therapeutic targets for a subset of patients, guiding diagnosis and treatments with IV immunoglobulin or immunoadsorption.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical and Research Infectious Diseases Department, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.
- Endocrinology Clinical Unit, San Camillo Forlanini Hospital, 00149 Rome, Italy.
- Institute of Molecular Systems Biology, Department of Biology, ETH Zürich, 8093 Zurich, Switzerland.
- Department of Clinical Pathology, San Camillo Forlanini Hospital, 00149 Rome, Italy.
- Azienda Sanitaria Locale ASL Roma 1, 00193 Rome, Italy.
- Laboratory of Cellular Immunology and Pharmacology, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, 00149 Rome, Italy.
ORCID-Profile: Marta Camici, Lorenzo Talamanca, Jessica Paulicelli, Valentina Mazzotta, Ilaria Mastrorosa, Eleonora Cimini, Stefania Notari, Paolo Zuppi, Maria Grazia Bocci, Fabrizio Maggi, Enrico Girardi, Andrea Antinori
Förderung
- Ricerca Corrente of the Italian Ministry of Health, Linea 1, Progetto 1, INMI L. Spallanzani I.R.C.C.S.
Zitieren
APA
Camici, M., Franco, M., Talamanca, L., Paulicelli, J., Scarnecchia, L., Petino, M., Mazzotta, V., Mastrorosa, I., Cimini, E., Tartaglia, E., Notari, S., Zuppi, P., Baldelli, R., Bocci, M. G., Maggi, F., Girardi, E., & Antinori, A. (2026). Prevalence of Circulating Autoantibodies Against G-Protein-Coupled Receptors as Potential Biomarkers for Long COVID: Preliminary Investigations. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27041787
Vancouver
Camici M, Franco M, Talamanca L, Paulicelli J, Scarnecchia L, Petino M, et al. Prevalence of Circulating Autoantibodies Against G-Protein-Coupled Receptors as Potential Biomarkers for Long COVID: Preliminary Investigations. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27041787
BibTeX
@article{Camici2026,
author = {Camici, Marta and Franco, Marta and Talamanca, Lorenzo and Paulicelli, Jessica and Scarnecchia, Liliana and Petino, Manuela and Mazzotta, Valentina and Mastrorosa, Ilaria and Cimini, Eleonora and Tartaglia, Eleonora and Notari, Stefania and Zuppi, Paolo and Baldelli, Roberto and Bocci, Maria Grazia and Maggi, Fabrizio and Girardi, Enrico and Antinori, Andrea},
title = {Prevalence of Circulating Autoantibodies Against G-Protein-Coupled Receptors as Potential Biomarkers for Long COVID: Preliminary Investigations},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27041787}
}
EUVIMED